Sabatolimab (anti-TIM-3)

Synonyms: MBG453, NVP-MBG453

Catalog No.A2037 Purity:99.44%

Sabatolimab (anti-TIM-3) (MBG453, NVP-MBG453) is a high-affinity, humanized IgG4 antibody targeting TIM-3 on the surface of T-cells.

Click to purchase the isotype control of Sabatolimab (anti-TIM-3)

Selleck's Sabatolimab (anti-TIM-3) has been cited by 2 publications

1 Customer Reviews

Purity & Quality Control

Batch: Purity: 99.44% Protein concentration: 6.3mg/ml Endotoxin Level: ＜1EU/mg

99.44

Choose Selective Immunology & Inflammation related Inhibitors

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description	Sabatolimab (anti-TIM-3) (MBG453, NVP-MBG453) is a high-affinity, humanized IgG4 antibody targeting TIM-3 on the surface of T-cells.

References
[1] Andrew M. Brunner, MD, et al. Blood (2020) 136 (Supplement 1): 1–2.

References

[1] Andrew M. Brunner, MD, et al. Blood (2020) 136 (Supplement 1): 1–2.

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	2252262-24-9
Molecular Weight	145 KD
Isotype	Human IgG4, κ
Application	Sabatolimab (anti-TIM-3)
Source	CHO cells
Purification	Protein G
Sterility	0.2 μM filtered
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

* Name Please enter your name.

* Email Please enter your email. Please enter a valid email address.

Phone

* Comments: Please write something to us.